trial

Models of Auditory Hallucination

NCTId NCT04210557
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Terminated
Enrollment 1 (actual)
Sponsored by Yale University
Primary completion 2021-04-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Terminated
Enrollment
1 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2020-02-27
Primary completion
2021-04-01
Eligibility
ALL · 18 Years · 45 Years

Interventions & indications

Drugs
Transcranial Magnetic Stimulation (TMS)

Sponsors

Yale UniversityLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Philip R Corlett, PhDPrincipal Investigator

Sites

1 total
New Haven, United States

Facts & assertions

4 sourced
Enrollment
1
Phase
NA
Primary Completion Date
2021-04-01
Status
TERMINATED
relationships
The graph out of here
drug
Transcranial Magnetic Stimulation (TMS)
drug
lead_sponsor
Yale University
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Schizo Affective Disorder
indication
Hallucinations
indication
Psychotic Disorders
indication
investigator
Philip R Corlett, PhD
person